Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Metlife (MET) EBITDA Margin (2016 - 2026)

Metlife's EBITDA Margin history spans 18 years, with the latest figure at 0.35% for Q1 2026.

  • Quarterly EBITDA Margin fell 2488.0% to 0.35% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 16.2% through Mar 2026, down 804.0% year-over-year, with the annual reading at 45.32% for FY2025, 201.0% down from the prior year.
  • EBITDA Margin came in at 0.35% for Q1 2026, down from 35.49% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 42.84% in Q4 2024 to a low of 46.22% in Q2 2022.
  • The 5-year median for EBITDA Margin is 6.49% (2025), against an average of 6.49%.
  • The largest YoY upside for EBITDA Margin was 8179bps in 2022 against a maximum downside of -7497bps in 2022.
  • Metlife's EBITDA Margin stood at 28.6% in 2022, then fell by -1bps to 28.2% in 2023, then soared by 52bps to 42.84% in 2024, then decreased by -17bps to 35.49% in 2025, then plummeted by -99bps to 0.35% in 2026.
  • Per Business Quant, the three most recent readings for MET's EBITDA Margin are 0.35% (Q1 2026), 35.49% (Q4 2025), and 18.41% (Q3 2025).